Need Help?

Vγ9Vδ2-T cells in chronic lymphocytic leukemia patients and healthy controls

RNA sequencing data from Vγ9Vδ2-T cells from chronic lymphocytic leukemia patients and age-mnatched healthy controls. Matched Vγ9Vδ2-T cell samples before and after expansion with autologous monocyte-derived dendritic cells for each donor are included.

Request Access

DUO:0000006
version: 2019-01-07

health or medical or biomedical research

This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.

Immunohematology data access policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (https://www.genome.gov/pages/research/wellcomereport0303.pdf) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS Dataset reference (EGA Study ID and Dataset Details) Improving CLL Vγ9Vδ2-T cell fitness for cellular therapy by ex vivo activation and ibrutinib Name of project that created the dataset Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands Names of other data producers/collaborators Iris de Weerdt, Tom Hofland; Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands Specific limitations on areas of research Not specified Minimum protection measures required File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands intends to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands anticipates that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until 12 months after these data were first made available on the relevant hosting database, unless Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with Arnon P. Kater, MD PhD, Amsterdam UMC, University of Amsterdam, Department of Hematology, Meibergdreef 9, Amsterdam, the Netherlands.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003193 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00002135029 fastq.gz 86.7 MB Report
EGAF00002135030 fastq.gz 83.9 MB Report
EGAF00002135031 fastq.gz 89.9 MB Report
EGAF00002135032 fastq.gz 87.2 MB Report
EGAF00002135033 fastq.gz 73.0 MB Report
EGAF00002135034 fastq.gz 71.4 MB Report
EGAF00002135035 fastq.gz 75.1 MB Report
EGAF00002135036 fastq.gz 73.1 MB Report
EGAF00002135037 fastq.gz 86.1 MB Report
EGAF00002135038 fastq.gz 83.8 MB Report
EGAF00002135039 fastq.gz 89.0 MB Report
EGAF00002135040 fastq.gz 86.7 MB Report
EGAF00002135041 fastq.gz 82.9 MB Report
EGAF00002135042 fastq.gz 81.1 MB Report
EGAF00002135043 fastq.gz 85.2 MB Report
EGAF00002135044 fastq.gz 83.0 MB Report
EGAF00002135045 fastq.gz 98.7 MB Report
EGAF00002135046 fastq.gz 96.6 MB Report
EGAF00002135047 fastq.gz 102.0 MB Report
EGAF00002135048 fastq.gz 99.3 MB Report
EGAF00002135049 fastq.gz 73.6 MB Report
EGAF00002135050 fastq.gz 70.8 MB Report
EGAF00002135051 fastq.gz 76.9 MB Report
EGAF00002135052 fastq.gz 74.1 MB Report
EGAF00002135053 fastq.gz 85.4 MB Report
EGAF00002135054 fastq.gz 82.2 MB Report
EGAF00002135055 fastq.gz 88.6 MB Report
EGAF00002135056 fastq.gz 85.7 MB Report
EGAF00002135057 fastq.gz 87.1 MB Report
EGAF00002135058 fastq.gz 85.3 MB Report
EGAF00002135059 fastq.gz 90.4 MB Report
EGAF00002135060 fastq.gz 88.6 MB Report
EGAF00002135061 fastq.gz 94.8 MB Report
EGAF00002135062 fastq.gz 93.3 MB Report
EGAF00002135063 fastq.gz 97.2 MB Report
EGAF00002135064 fastq.gz 95.3 MB Report
EGAF00002135065 fastq.gz 101.3 MB Report
EGAF00002135066 fastq.gz 99.7 MB Report
EGAF00002135067 fastq.gz 105.0 MB Report
EGAF00002135068 fastq.gz 102.9 MB Report
EGAF00002135069 fastq.gz 76.3 MB Report
EGAF00002135070 fastq.gz 75.1 MB Report
EGAF00002135071 fastq.gz 79.5 MB Report
EGAF00002135072 fastq.gz 78.6 MB Report
EGAF00002135073 fastq.gz 98.7 MB Report
EGAF00002135074 fastq.gz 96.6 MB Report
EGAF00002135075 fastq.gz 102.4 MB Report
EGAF00002135076 fastq.gz 100.1 MB Report
EGAF00002135077 fastq.gz 102.7 MB Report
EGAF00002135078 fastq.gz 100.7 MB Report
EGAF00002135079 fastq.gz 106.2 MB Report
EGAF00002135080 fastq.gz 104.2 MB Report
EGAF00002135081 fastq.gz 83.1 MB Report
EGAF00002135082 fastq.gz 81.5 MB Report
EGAF00002135083 fastq.gz 86.3 MB Report
EGAF00002135084 fastq.gz 84.5 MB Report
EGAF00002135085 fastq.gz 102.2 MB Report
EGAF00002135086 fastq.gz 100.5 MB Report
EGAF00002135087 fastq.gz 105.6 MB Report
EGAF00002135088 fastq.gz 103.4 MB Report
EGAF00002135089 fastq.gz 94.7 MB Report
EGAF00002135090 fastq.gz 93.1 MB Report
EGAF00002135091 fastq.gz 98.6 MB Report
EGAF00002135092 fastq.gz 96.7 MB Report
EGAF00002135093 fastq.gz 123.8 MB Report
EGAF00002135094 fastq.gz 121.4 MB Report
EGAF00002135095 fastq.gz 127.8 MB Report
EGAF00002135096 fastq.gz 123.8 MB Report
EGAF00002135097 fastq.gz 239.1 MB Report
EGAF00002135098 fastq.gz 236.1 MB Report
EGAF00002135099 fastq.gz 245.7 MB Report
EGAF00002135100 fastq.gz 238.7 MB Report
EGAF00002135101 fastq.gz 135.9 MB Report
EGAF00002135102 fastq.gz 134.3 MB Report
EGAF00002135103 fastq.gz 140.4 MB Report
EGAF00002135104 fastq.gz 136.7 MB Report
EGAF00002135105 fastq.gz 140.4 MB Report
EGAF00002135106 fastq.gz 139.3 MB Report
EGAF00002135107 fastq.gz 144.7 MB Report
EGAF00002135108 fastq.gz 140.8 MB Report
EGAF00002135109 fastq.gz 22.6 MB Report
EGAF00002135110 fastq.gz 22.3 MB Report
EGAF00002135111 fastq.gz 23.2 MB Report
EGAF00002135112 fastq.gz 22.7 MB Report
EGAF00002135113 fastq.gz 177.8 MB Report
EGAF00002135114 fastq.gz 173.9 MB Report
EGAF00002135115 fastq.gz 182.3 MB Report
EGAF00002135116 fastq.gz 177.1 MB Report
EGAF00002135117 fastq.gz 129.7 MB Report
EGAF00002135118 fastq.gz 126.7 MB Report
EGAF00002135119 fastq.gz 133.6 MB Report
EGAF00002135120 fastq.gz 129.5 MB Report
EGAF00002135121 fastq.gz 123.3 MB Report
EGAF00002135122 fastq.gz 122.8 MB Report
EGAF00002135123 fastq.gz 127.5 MB Report
EGAF00002135124 fastq.gz 124.9 MB Report
EGAF00002135125 fastq.gz 69.2 MB Report
EGAF00002135126 fastq.gz 69.0 MB Report
EGAF00002135127 fastq.gz 71.2 MB Report
EGAF00002135128 fastq.gz 69.5 MB Report
EGAF00002135129 fastq.gz 17.5 MB Report
EGAF00002135130 fastq.gz 17.4 MB Report
EGAF00002135131 fastq.gz 18.1 MB Report
EGAF00002135132 fastq.gz 17.7 MB Report
EGAF00002135133 fastq.gz 212.4 MB Report
EGAF00002135134 fastq.gz 213.0 MB Report
EGAF00002135135 fastq.gz 221.6 MB Report
EGAF00002135136 fastq.gz 218.1 MB Report
EGAF00002135137 fastq.gz 42.6 MB Report
EGAF00002135138 fastq.gz 42.1 MB Report
EGAF00002135139 fastq.gz 43.9 MB Report
EGAF00002135140 fastq.gz 42.8 MB Report
EGAF00002135141 fastq.gz 18.5 MB Report
EGAF00002135142 fastq.gz 18.3 MB Report
EGAF00002135143 fastq.gz 19.0 MB Report
EGAF00002135144 fastq.gz 18.6 MB Report
EGAF00002135145 fastq.gz 154.7 MB Report
EGAF00002135146 fastq.gz 153.6 MB Report
EGAF00002135147 fastq.gz 159.8 MB Report
EGAF00002135148 fastq.gz 156.3 MB Report
EGAF00002135149 fastq.gz 23.5 MB Report
EGAF00002135150 fastq.gz 23.5 MB Report
EGAF00002135151 fastq.gz 24.4 MB Report
EGAF00002135152 fastq.gz 23.8 MB Report
EGAF00002135153 fastq.gz 63.7 MB Report
EGAF00002135154 fastq.gz 63.4 MB Report
EGAF00002135155 fastq.gz 66.1 MB Report
EGAF00002135156 fastq.gz 64.6 MB Report
EGAF00002135157 fastq.gz 120.4 MB Report
EGAF00002135158 fastq.gz 117.8 MB Report
EGAF00002135159 fastq.gz 125.0 MB Report
EGAF00002135160 fastq.gz 121.6 MB Report
EGAF00002135161 fastq.gz 100.1 MB Report
EGAF00002135162 fastq.gz 98.6 MB Report
EGAF00002135163 fastq.gz 103.5 MB Report
EGAF00002135164 fastq.gz 101.0 MB Report
EGAF00002135165 fastq.gz 119.9 MB Report
EGAF00002135166 fastq.gz 118.0 MB Report
EGAF00002135167 fastq.gz 124.4 MB Report
EGAF00002135168 fastq.gz 121.3 MB Report
EGAF00002135169 fastq.gz 115.2 MB Report
EGAF00002135170 fastq.gz 113.8 MB Report
EGAF00002135171 fastq.gz 118.9 MB Report
EGAF00002135172 fastq.gz 116.2 MB Report
EGAF00002135173 fastq.gz 137.6 MB Report
EGAF00002135174 fastq.gz 136.2 MB Report
EGAF00002135175 fastq.gz 142.5 MB Report
EGAF00002135176 fastq.gz 139.4 MB Report
EGAF00002135177 fastq.gz 105.4 MB Report
EGAF00002135178 fastq.gz 103.0 MB Report
EGAF00002135179 fastq.gz 108.5 MB Report
EGAF00002135180 fastq.gz 105.8 MB Report
EGAF00002135181 fastq.gz 119.1 MB Report
EGAF00002135182 fastq.gz 116.5 MB Report
EGAF00002135183 fastq.gz 123.3 MB Report
EGAF00002135184 fastq.gz 120.0 MB Report
EGAF00002135185 fastq.gz 120.9 MB Report
EGAF00002135186 fastq.gz 119.6 MB Report
EGAF00002135187 fastq.gz 125.6 MB Report
EGAF00002135188 fastq.gz 123.4 MB Report
EGAF00002135189 fastq.gz 129.8 MB Report
EGAF00002135190 fastq.gz 128.6 MB Report
EGAF00002135191 fastq.gz 134.0 MB Report
EGAF00002135192 fastq.gz 131.6 MB Report
EGAF00002135193 fastq.gz 140.0 MB Report
EGAF00002135194 fastq.gz 139.0 MB Report
EGAF00002135195 fastq.gz 145.2 MB Report
EGAF00002135196 fastq.gz 143.0 MB Report
EGAF00002135197 fastq.gz 104.1 MB Report
EGAF00002135198 fastq.gz 103.7 MB Report
EGAF00002135199 fastq.gz 109.1 MB Report
EGAF00002135200 fastq.gz 107.6 MB Report
EGAF00002135201 fastq.gz 136.7 MB Report
EGAF00002135202 fastq.gz 135.1 MB Report
EGAF00002135203 fastq.gz 141.8 MB Report
EGAF00002135204 fastq.gz 139.1 MB Report
EGAF00002135205 fastq.gz 141.0 MB Report
EGAF00002135206 fastq.gz 139.4 MB Report
EGAF00002135207 fastq.gz 146.2 MB Report
EGAF00002135208 fastq.gz 143.6 MB Report
EGAF00002135209 fastq.gz 114.2 MB Report
EGAF00002135210 fastq.gz 112.7 MB Report
EGAF00002135211 fastq.gz 118.5 MB Report
EGAF00002135212 fastq.gz 116.1 MB Report
EGAF00002135213 fastq.gz 142.2 MB Report
EGAF00002135214 fastq.gz 140.5 MB Report
EGAF00002135215 fastq.gz 147.6 MB Report
EGAF00002135216 fastq.gz 144.5 MB Report
EGAF00002135217 fastq.gz 130.5 MB Report
EGAF00002135218 fastq.gz 129.2 MB Report
EGAF00002135219 fastq.gz 135.9 MB Report
EGAF00002135220 fastq.gz 133.2 MB Report
EGAF00002135221 fastq.gz 120.5 MB Report
EGAF00002135222 fastq.gz 115.2 MB Report
EGAF00002135223 fastq.gz 120.3 MB Report
EGAF00002135224 fastq.gz 117.5 MB Report
EGAF00002135225 fastq.gz 99.5 MB Report
EGAF00002135226 fastq.gz 96.0 MB Report
EGAF00002135227 fastq.gz 99.4 MB Report
EGAF00002135228 fastq.gz 98.0 MB Report
EGAF00002135229 fastq.gz 118.8 MB Report
EGAF00002135230 fastq.gz 114.2 MB Report
EGAF00002135231 fastq.gz 118.5 MB Report
EGAF00002135232 fastq.gz 116.8 MB Report
EGAF00002135233 fastq.gz 113.8 MB Report
EGAF00002135234 fastq.gz 109.9 MB Report
EGAF00002135235 fastq.gz 113.4 MB Report
EGAF00002135236 fastq.gz 112.2 MB Report
EGAF00002135237 fastq.gz 137.4 MB Report
EGAF00002135238 fastq.gz 132.6 MB Report
EGAF00002135239 fastq.gz 137.1 MB Report
EGAF00002135240 fastq.gz 135.4 MB Report
EGAF00002135241 fastq.gz 105.8 MB Report
EGAF00002135242 fastq.gz 101.2 MB Report
EGAF00002135243 fastq.gz 105.6 MB Report
EGAF00002135244 fastq.gz 103.4 MB Report
EGAF00002135245 fastq.gz 119.7 MB Report
EGAF00002135246 fastq.gz 113.9 MB Report
EGAF00002135247 fastq.gz 119.5 MB Report
EGAF00002135248 fastq.gz 116.4 MB Report
EGAF00002135249 fastq.gz 119.9 MB Report
EGAF00002135250 fastq.gz 116.3 MB Report
EGAF00002135251 fastq.gz 119.5 MB Report
EGAF00002135252 fastq.gz 118.6 MB Report
EGAF00002135253 fastq.gz 128.4 MB Report
EGAF00002135254 fastq.gz 124.8 MB Report
EGAF00002135255 fastq.gz 128.1 MB Report
EGAF00002135256 fastq.gz 127.4 MB Report
EGAF00002135257 fastq.gz 139.5 MB Report
EGAF00002135258 fastq.gz 135.5 MB Report
EGAF00002135259 fastq.gz 139.3 MB Report
EGAF00002135260 fastq.gz 138.1 MB Report
EGAF00002135261 fastq.gz 103.3 MB Report
EGAF00002135262 fastq.gz 100.7 MB Report
EGAF00002135263 fastq.gz 103.1 MB Report
EGAF00002135264 fastq.gz 102.6 MB Report
EGAF00002135265 fastq.gz 136.4 MB Report
EGAF00002135266 fastq.gz 131.9 MB Report
EGAF00002135267 fastq.gz 136.2 MB Report
EGAF00002135268 fastq.gz 134.5 MB Report
EGAF00002135269 fastq.gz 140.7 MB Report
EGAF00002135270 fastq.gz 136.1 MB Report
EGAF00002135271 fastq.gz 140.5 MB Report
EGAF00002135272 fastq.gz 139.0 MB Report
EGAF00002135273 fastq.gz 113.2 MB Report
EGAF00002135274 fastq.gz 109.8 MB Report
EGAF00002135275 fastq.gz 113.1 MB Report
EGAF00002135276 fastq.gz 112.0 MB Report
EGAF00002135277 fastq.gz 139.6 MB Report
EGAF00002135278 fastq.gz 135.0 MB Report
EGAF00002135279 fastq.gz 139.1 MB Report
EGAF00002135280 fastq.gz 138.2 MB Report
EGAF00002135281 fastq.gz 130.0 MB Report
EGAF00002135282 fastq.gz 126.3 MB Report
EGAF00002135283 fastq.gz 129.7 MB Report
EGAF00002135284 fastq.gz 128.6 MB Report
EGAF00002135285 fastq.gz 106.8 MB Report
EGAF00002135286 fastq.gz 102.6 MB Report
EGAF00002135287 fastq.gz 106.6 MB Report
EGAF00002135288 fastq.gz 105.1 MB Report
EGAF00002135289 fastq.gz 89.8 MB Report
EGAF00002135290 fastq.gz 86.8 MB Report
EGAF00002135291 fastq.gz 88.7 MB Report
EGAF00002135292 fastq.gz 87.9 MB Report
EGAF00002135293 fastq.gz 105.3 MB Report
EGAF00002135294 fastq.gz 101.7 MB Report
EGAF00002135295 fastq.gz 104.6 MB Report
EGAF00002135296 fastq.gz 104.0 MB Report
EGAF00002135297 fastq.gz 101.6 MB Report
EGAF00002135298 fastq.gz 98.7 MB Report
EGAF00002135299 fastq.gz 100.4 MB Report
EGAF00002135300 fastq.gz 99.8 MB Report
EGAF00002135301 fastq.gz 122.5 MB Report
EGAF00002135302 fastq.gz 118.8 MB Report
EGAF00002135303 fastq.gz 121.8 MB Report
EGAF00002135304 fastq.gz 120.7 MB Report
EGAF00002135305 fastq.gz 94.9 MB Report
EGAF00002135306 fastq.gz 91.1 MB Report
EGAF00002135307 fastq.gz 94.2 MB Report
EGAF00002135308 fastq.gz 92.8 MB Report
EGAF00002135309 fastq.gz 106.3 MB Report
EGAF00002135310 fastq.gz 101.8 MB Report
EGAF00002135311 fastq.gz 105.8 MB Report
EGAF00002135312 fastq.gz 104.4 MB Report
EGAF00002135313 fastq.gz 106.4 MB Report
EGAF00002135314 fastq.gz 103.8 MB Report
EGAF00002135315 fastq.gz 106.2 MB Report
EGAF00002135316 fastq.gz 106.2 MB Report
EGAF00002135317 fastq.gz 115.7 MB Report
EGAF00002135318 fastq.gz 113.1 MB Report
EGAF00002135319 fastq.gz 114.4 MB Report
EGAF00002135320 fastq.gz 114.1 MB Report
EGAF00002135321 fastq.gz 124.8 MB Report
EGAF00002135322 fastq.gz 121.5 MB Report
EGAF00002135323 fastq.gz 124.5 MB Report
EGAF00002135324 fastq.gz 123.8 MB Report
EGAF00002135325 fastq.gz 90.8 MB Report
EGAF00002135326 fastq.gz 88.6 MB Report
EGAF00002135327 fastq.gz 91.4 MB Report
EGAF00002135328 fastq.gz 92.0 MB Report
EGAF00002135329 fastq.gz 122.4 MB Report
EGAF00002135330 fastq.gz 118.5 MB Report
EGAF00002135331 fastq.gz 122.2 MB Report
EGAF00002135332 fastq.gz 121.2 MB Report
EGAF00002135333 fastq.gz 126.1 MB Report
EGAF00002135334 fastq.gz 122.6 MB Report
EGAF00002135335 fastq.gz 125.5 MB Report
EGAF00002135336 fastq.gz 125.1 MB Report
EGAF00002135337 fastq.gz 101.2 MB Report
EGAF00002135338 fastq.gz 98.2 MB Report
EGAF00002135339 fastq.gz 100.9 MB Report
EGAF00002135340 fastq.gz 100.6 MB Report
EGAF00002135341 fastq.gz 124.5 MB Report
EGAF00002135342 fastq.gz 121.3 MB Report
EGAF00002135343 fastq.gz 123.2 MB Report
EGAF00002135344 fastq.gz 123.1 MB Report
EGAF00002135345 fastq.gz 116.1 MB Report
EGAF00002135346 fastq.gz 112.9 MB Report
EGAF00002135347 fastq.gz 116.0 MB Report
EGAF00002135348 fastq.gz 115.6 MB Report
320 Files (35.3 GB)